| ²é¿´: 695 | »Ø¸´: 1 | |||||||||||||||||
Èó¼Ñҽҩгæ (³õÈëÎÄ̳)
|
[½»Á÷]
ËÕÖÝÒ½Ò©Ñз¢ÆóÒµÕÐÆ¸¸ß¼¶Ò©ÎﻯѧÑо¿Ô±/Ò©»¯²¿Ö÷ÈÎ
|
¸Úλ£º¸ß¼¶Ò©ÎﻯѧÑо¿Ô±/Ò©»¯²¿Ö÷ÈÎ ¹¤×÷ÄêÏÞ£º2ÄêÒÔÉÏ Ñ§Àú£º²©Ê¿ Ö°ÄÜ£ºÒ½Ò©¼¼ÊõÑз¢ÈËÔ± ְλÃèÊö: 1. ´øÁìÒ»Ö§Ò©ÎïÑз¢ÍŶӣ¬Ö¸µ¼ºÍ¼à¹ÜÐÂÐÍÒ©ÎïµÄÉè¼ÆÓëºÏ³ÉÏîÄ¿¡£ 2. Áìµ¼¼°¹ÜÀíÒ©Îﻯѧ¿ª·¢²¿£¬¶ÀÁ¢¸ºÔðÒ©ÎïÑз¢ÏîÄ¿¡£ 3. Ö¸µ¼¿ÎÌâ×鳤¼°Ñо¿Ô±´ÓÊÂʵÑéºÏ³É·ÏßµÄ̽Ë÷ÓëÉè¼Æ£¬»ý¼«ÌáÉýÑо¿Ô±¼°ºÏ³ÉÈËÔ±µÄ¿ÆÑм°¼¼Êõˮƽ¡£ 4. ¸ºÔð±¾²¿ÃÅÄÚSOPµÄÖÆ¶¨£¬È·±£¸÷Ï×÷ÄܸßЧÇÒ°²È«µÄ½øÐС£ 5. е÷ÓëÉúÎﻯѧ¡¢Ò©ÀíѧµÈÁÙ´²Ç°Ñо¿Ïà¹Ø²¿ÃŵĺÏ×÷¼°¹²Í¬³Ðµ£ÏîÄ¿µÄ¼Æ»®Óëʵʩ¡£ 6. ¸ºÔðÒ©ÎïÉè¼ÆÓëºÏ³Éм¼ÊõµÄÐÅÏ¢¸ú×Ù£»¸ºÔð¹ÜÀíʵÑ鱨¸æ¼°É걨×ÊÁϵĹéÄÉÓë»ã×Ü¡£ 7. ÐÖúÑз¢¸±×ܲöÔÒ©Î↑·¢µÄÁ¢Ïî¿ÉÐÐÐÔÑо¿£¬²¢¶¨ÆÚÏò¸±×ܻ㱨ÏîÄ¿½ø¶È¡£ Expectations: Lead and conduct research in small-molecule based drug development; lead and supervise research scientists; play important roles in and make great contributions to drug development programs and projects; prepare research plans, reports and presentations; and report to VP Research. ¸ÚλҪÇó£º 1. Óлú»¯Ñ§¡¢Ò©ÎﻯѧµÈÏà¹Ø×¨Òµ²©Ê¿Ñ§Àú£¬¾ßÓÐ2ÄêÒÔÉÏÓëÒ©Î↑·¢ÓйصŤ×÷¾Ñé¡£ 2. ·á¸»µÄÒ©ÎïÉè¼Æ¹¤×÷¾Ñ飬ÊìÁ·ÕÆÎÕÓлúºÏ³É¡¢²úÎï·ÖÀëÓë½á¹¹¼ø¶¨µÈÏà¹Ø¼¼ÄÜ¡£ 3. ½ÏÇ¿µÄÁìµ¼ºÍ¹ÜÀíÄÜÁ¦£¬ÉƳ¤Ó벻ͬ²ã´Î¿ÆÑм°¹ÜÀíÈËÔ±¹µÍ¨£»ÓÅÐãµÄÖ°ÒµËØÑøºÍÕæ³ÏµÄÍŶӺÏ×÷¾«Éñ¡£ 4. Á¼ºÃµÄÓ¢ÓïʹÓÃÄÜÁ¦£¬Äܹ»ÊìÁ·²éÔĸ÷ÖÖÎÄÏס£ Qualifications: Ph.D. in medicinal/synthetic chemistry or closely related fields with research experience, ideally in industrial setting or research institutional environment; innovative and initiative; strong team player and good leadership in drug discovery and medicinal chemistry with excellent interpersonal and communication skills; good research records in scientific publications and/or patent applications; and able to communicate in English. ¹«Ë¾½éÉÜ£º Èó¼Ñ£¨ËÕÖÝ£©Ò½Ò©¿Æ¼¼ÓÐÏÞ¹«Ë¾Î»ÓÚËÕÖݹ¤ÒµÔ°ÇøÉúÎïÄÉÃ×Ô°£¬ÊÇÒ»¼ÒÒÔ1.1ÀàС·Ö×ÓÒ©ÎïÑз¢ÎªÖ÷µÄ¸ß¿Æ¼¼ÆóÒµ¡£¹«Ë¾×¢²á×ʱ¾ÈËÃñ±Ò5000Íò£¬¹«Ë¾ÍŶÓÓɶàÃû¹úÄÚÍâÏíÓþÊ¢ÃûµÄ¿ÆÑ§¼Ò¡¢½ÌÊÚ¡¢ÔºÊ¿ÁìÏΡ£¹«Ë¾Å䱸500Õ׺˴ʲÕñµÈÒ»Á÷µÄÓ²¼þÉèÊ©¡¢ÉèÓйú¼Ê±ê×¼µÄʵÑéÊÒ£¬ÒÔ¼°¹ú¼Ê»¯µÄÍâÆó¹ÜÀíÎÄ»¯£¬½«¸øÓèÔ±¹¤Á¼ºÃµÄ¹¤×÷»·¾³¡¢ÓźñµÄ´ýÓöÒÔ¼°³öÉ«µÄÖ°Òµ·¢Õ¹Æ½Ì¨¡£ |
» ²ÂÄãϲ»¶
0703»¯Ñ§Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
ר˶310Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
¿¼Ñе÷¼Á-²ÄÁÏÀà-284
ÒѾÓÐ8È˻ظ´
266Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
265Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
070300»¯Ñ§279Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
²ÄÁϹ¤³Ì085601£¬270Çóµ÷¼Á
ÒѾÓÐ16È˻ظ´
²ÄÁÏ»¯¹¤×Ü·Ö334Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
²ÄÁÏ¿¼ÑÐÇóµ÷¼Á×Ü·Ö280
ÒѾÓÐ33È˻ظ´
293·ÖÇóµ÷¼Á£¬ÍâÓïΪ¶íÓï
ÒѾÓÐ10È˻ظ´
|
2Â¥2016-03-31 11:32:56














»Ø¸´´ËÂ¥